U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07381816) titled 'GastroFlow: Investigation of the Gastrointestinal Blood Flow in Patients With Postprandial Hypotension' on Sept. 03, 2025.
Brief Summary: This project will describe the mechanisms of action and the relative contributions of GIP to changes in gastrointestinal blood flow induced by oral glucose and endogenous GIP with the use of a receptor antagonists GIP(3-30)NH2 in patients with postprandial hypotension.
Study Start Date: Sept. 15, 2025
Study Type: INTERVENTIONAL
Condition:
Postprandial Hypotension
Healthy
Blood Flow
Intervention:
OTHER: MRI + GIPR antagonist (Tool)
GIP(3-30)NH2 infusion, oral glucose during MRI scans
OTHER: ...